Upadacitinib is a DMARD used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondyloarthritis (AS), by inhibiting an enzyme called Janus kinase which would otherwise trigger numerous inflammatory reactions. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
Drug Class: Janus Kinase (JAK) Inhibitor
Tofacitinib
Tofacitinib is a DMARD used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA) and psoriatic arthritis (PsA), by inhibiting an enzyme called Janus kinase (JAK) which would otherwise trigger numerous inflammatory reactions. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
Baricitinib
Baricitinib is a Disease-Modifying Anti-Rheumatic Drug (DMARD) used to treat rheumatoid arthritis (RA) by inhibiting an enzyme called Janus kinase (JAK) which would otherwise trigger numerous inflammatory reactions. Baricitinib can help suppress an overactive immune system but can also increase your risk of certain infections.
